Correlation Between Alphabet and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Alphabet and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Vir Biotechnology, you can compare the effects of market volatilities on Alphabet and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Vir Biotechnology.
Diversification Opportunities for Alphabet and Vir Biotechnology
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alphabet and Vir is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Alphabet i.e., Alphabet and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Alphabet and Vir Biotechnology
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.37 times more return on investment than Vir Biotechnology. However, Alphabet Inc Class C is 2.69 times less risky than Vir Biotechnology. It trades about -0.02 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.06 per unit of risk. If you would invest 17,758 in Alphabet Inc Class C on August 24, 2024 and sell it today you would lose (834.00) from holding Alphabet Inc Class C or give up 4.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Vir Biotechnology
Performance |
| Timeline |
| Alphabet Class C |
| Vir Biotechnology |
Alphabet and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Vir Biotechnology
The main advantage of trading using opposite Alphabet and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.The idea behind Alphabet Inc Class C and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Vir Biotechnology vs. ZyVersa Therapeutics | Vir Biotechnology vs. Sonnet Biotherapeutics Holdings | Vir Biotechnology vs. Zura Bio Limited | Vir Biotechnology vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets |